ADORX THERAPEUTICS LIMITED - Profile & Financials

Accounts Submitted 28 Nov 2025

Confirmation Statement Submitted 24 Feb 2025

Net assets £7.85M £2.85M 2023 year on year

Total assets £9.22M £3.39M 2023 year on year

Total Liabilities £1.37M £532.65K 2023 year on year

Charges 1

1 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

137a George Street Edinburgh EH2 4JY

Telephone

0131 243 3704

info@adorx.com

Website

adorx.com

Credit Report

Discover ADORX THERAPEUTICS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2017–2023)

Cash in Bank

£5.44M

Decreased by £7.05M (-56%)

Net Assets

£7.85M

Decreased by £2.85M (-27%)

Total Liabilities

£1.37M

Decreased by £532.65k (-28%)

Turnover

£12.80M

Decreased by £1.22M (-9%)

Employees

Debt Ratio

15%

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

3 active 1 resigned

Show resigned officers

						Status
Ian Miscampbell	Director	British	United Kingdom	64	9 Mar 2018	Active
Kyparissia Katie Sirinakis	Director	American	America	60	21 Feb 2023	Active
Peter Michael Finan	Director	British	England	58	24 Feb 2017	Active

Shareholders

Shareholders (16)


Sarah Jane Mccarthy	1.2%	45,360	Ordinary Shares	20 Mar 2024
Roy Pettifer	0.3%	11,264	Deferred Shares	20 Mar 2024
Tim Hamond	0.0%	0	Ordinary Shares	20 Mar 2024

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Crt Pioneer Gp Limited

United Kingdom

Active

Notified 9 Mar 2018

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent

Epidarex Capital Partners Limited

United Kingdom

Active

Notified 24 Feb 2017

Nature of Control

Ownership Of Shares 50 To 75 Percent
Voting Rights 50 To 75 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

EPIDAREX CAPITAL PARTNERS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

CRT PIONEER GP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

SIXTH ELEMENT CAPITAL LLP united kingdom

EPIDAREX MANAGEMENT LTD united kingdom

ADORX THERAPEUTICS LIMITED Current Company

Charges

1 satisfied

Documents

Company Filings

Date	Category	Description	Document
28 Nov 2025	Accounts	Annual accounts made up to 2025-02-28	View(23 pages)
24 Feb 2025	Confirmation Statement	Confirmation statement made on 2025-02-24 with updates	View(5 pages)
24 Sept 2024	Accounts	Annual accounts made up to 2024-02-28	View(23 pages)
20 Mar 2024	Confirmation Statement	Confirmation statement made on 2024-02-24 with updates	View(7 pages)
20 Dec 2023	Incorporation	Memorandum Articles	View(78 pages)